Clinical Trial Update: PULSAR in Systemic Therapy for Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial (PULSAR) evaluating systemic therapy for pancreatic ductal adenocarcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: Samsung Medical Center | Conditions: Locally Advanced Pancreatic Ductal Adenocarcinoma, Borderline Resectable Pancreatic Ductal Adenocarcinoma | Phase 2 | Status: RECRUITING